2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition
Abstract Cyclic phosphatidic acid (cPA) is a naturally occurring phospholipid mediator that, along with its chemically stabilized analogue 2-carba-cyclic phosphatidic acid (2ccPA), induces various biological activities in vitro and in vivo. Although cPA is similar to lysophosphatidic acid (LPA) in s...
Main Authors: | Keiko Fukasawa, Mari Gotoh, Akiharu Uwamizu, Takatsugu Hirokawa, Masaki Ishikawa, Yoshibumi Shimizu, Shinji Yamamoto, Kensuke Iwasa, Keisuke Yoshikawa, Junken Aoki, Kimiko Murakami-Murofushi |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-08-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-96931-2 |
Similar Items
-
Autotaxin–Lysophosphatidic Acid Signaling in Alzheimer’s Disease
by: Sindhu Ramesh, et al.
Published: (2018-06-01) -
Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development
by: Silvia Anahi Valdés-Rives, et al.
Published: (2017-01-01) -
Autotaxin, lysophosphatidate and taxol resistance
by: Samadi, Nasser
Published: (2009) -
MicroRNA Regulation of the Autotaxin-Lysophosphatidic Acid Signaling Axis
by: Mandi M. Murph
Published: (2019-09-01) -
Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain
by: Chun Jerold, et al.
Published: (2008-02-01)